Healthtech Startups

Ourry Medical is a healthcare company focused on integrating and improving expertise centered on patient outcomes, combining technology and human expertise to deliver comprehensive solutions for healthcare needs.

1 investor

OutcomeMD operates a data network that collects patient-reported outcome measures (PROMs) from clinicians and transforms them into insights for providers, health systems, and researchers. The platform serves healthcare providers, practice groups, biopharma companies, and researchers seeking to improve patient outcomes and access real-world clinical data.

1 investor

OutcomesAI combines AI voice agents with licensed nurses to deliver scalable, high-quality care across hospitals, virtual care, and specialty programs. The platform automates routine clinical tasks like triage, documentation, and scheduling while enabling nurses to focus on complex, high-value patient interactions.

1 investor

Outdefine provides a governed decisioning and execution layer for clinical trial teams, using trial-trained AI inference and workflow agents to support site feasibility ranking, study risk monitoring, and real-world evidence analysis. It sits above existing clinical systems to connect trial data, protocol rules, and outcomes for pharmaceutical and life sciences operations.

1 investor

Outlook Therapeutics develops ophthalmic therapies for retinal diseases, including anti-VEGF treatments for conditions such as neovascular (wet) age-related macular degeneration, diabetic macular edema, and branch retinal vein occlusion. Its lead product, LYTENAVA (bevacizumab-vikg), is an FDA-approved ophthalmic bevacizumab formulation for adults with wet AMD.

1 investor

A platform that combines athlete assessment, velocity-based training guidance, and performance data analysis to help strength and conditioning professionals design and manage training programs. It integrates real-time biometric feedback with program management for individual athletes and teams.

1 investor

Outset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers. The company manufactures in North America and operates across the United States.

1 investor

Overdrive Health provides AI-powered medical billing services that automate the revenue cycle for healthcare providers, including insurance discovery, eligibility verification, coding, claims submission, and denial management. The platform combines automated technology with human oversight to reduce administrative burden and improve billing efficiency for medical practices.

1 investor

Overture develops precision antibody therapeutics for obesity treatment, targeting metabolic dysfunction pathways to reduce fat mass while preserving lean muscle through monthly-dosed therapeutic approaches.

1 investor

Ovianta is an AI platform for medical clinics and hospitals that deploys voice agents and automated workflows to handle patient calls, appointment scheduling, reminders, waitlist filling, and outreach campaigns via phone or WhatsApp. It integrates with clinic-management systems and telephony, enriches patient records, and provides analytics dashboards, with support for Spanish clinic systems and GDPR compliance.

1 investor

Ovum is a virtual healthcare practice specializing in preconception, pregnancy, postpartum, and hormonal health for women and men, featuring integrated specialist teams and evidence-based lifestyle medicine approaches covered by 240+ insurance plans across 20 US states.

1 investor

Ownmed Innovation is a spin-off that develops medical devices and technologies to address unmet clinical needs, taking products through preclinical studies, clinical trials, and CE certification under EU regulation 2017/745. Its focus includes ostomy care, with a device aimed at restoring continence.

1 investor

Oxford provides AI advisory and consulting services, helping organizations with AI strategy, governance, readiness assessment, pilot execution, and adoption planning to move from experimentation to measurable business value. It supports enterprise clients across the full AI lifecycle through staffing, co-managed, or full delivery engagement models.

1 investor

Oxford Medical Products develops medical devices, drawing on a team of biotech entrepreneurs, material scientists, polymer chemists and medical device engineers.

1 investor

OXOS develops portable digital radiography devices for orthopedic surgery, enabling point-of-care diagnostic imaging in medical facilities and surgical settings nationwide. The company manufactures the MC2, an advanced iteration of its original Micro C device designed to expand access to radiographic diagnostics.

1 investor

Oxurion is a French specialist in clinical biometrics and data management, providing the core technology for the Oxurion platform.

1 investor

OxVent designs and produces a low-cost electro-mechanical medical ventilator, originally developed for the UK Government's 2020 Ventilator Challenge by engineers and medics from the University of Oxford and King's College London. Operating as a social venture, the company deploys its ventilator for use during and beyond the COVID-19 pandemic.

1 investor

OxyPrem develops non-invasive sensors that provide real-time monitoring of oxygen levels in human tissue, aimed at neonatal intensive care and the treatment of premature and other vulnerable patients. Its technology targets clinical teams, with an early focus on the Swiss NICU market.

1 investor

Oya Care operates women's health clinics in São Paulo offering in-person and online gynecological consultations, exams, procedures, egg freezing, and surgeries, paired with a digital platform to manage appointments, exams, and medical history. It serves women seeking specialized healthcare in Brazil.

1 investor

oyora operates a network of medical facilities offering interdisciplinary diagnostics and treatment, with a focus on radiology using cross-sectional imaging equipment. It coordinates specialists across locations to provide patient care in Germany, open to patients regardless of insurance type.

1 investor

P95 is a clinical research and pharmaceutical services company that supports pharmaceutical development through medical monitoring, epidemiology, biostatistics, study management, pharmacovigilance, and medical writing services.

1 investor

P-Mind develops non-invasive therapeutic technologies based on decades of research into magnetic fields and their interaction with living organisms, with a focus on treating pain disorders, neurological diseases, and cancer. The company manufactures and sells medical devices, including the alternating magnetic field therapy device "Eight" (エイト).

1 investor

P3 Therapeutics is developing a new class of anti-inflammatory small chemical molecules and works with partners on a humanized gut-entheseal organ-on-chip platform to study their mechanism of action, pharmacokinetics, pharmacodynamics, and biomarkers. The work is part of an application to the EUROSTARS 3 program under the TRIGG3R project.

1 investor

Heidi Health is an AI-powered clinical documentation platform that captures patient encounters through real-time transcription and automatically generates structured clinical notes, reducing administrative burden on clinicians. The platform serves healthcare providers globally across 116 countries and supports workflow automation including task coordination, clinical coding, and patient outreach.

1 investor